Addus HomeCare (ADUS) Competitors $133.87 +0.55 (+0.41%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ADUS vs. HIMS, RDNT, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, and CONShould you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Hims & Hers Health (HIMS), RadNet (RDNT), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Addus HomeCare vs. Hims & Hers Health RadNet Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Addus HomeCare (NASDAQ:ADUS) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, community ranking, valuation, earnings, analyst recommendations and media sentiment. Which has more volatility & risk, ADUS or HIMS? Addus HomeCare has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Hims & Hers Health has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Is ADUS or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Addus HomeCare's net margin of 6.50%. Hims & Hers Health's return on equity of 10.97% beat Addus HomeCare's return on equity.Company Net Margins Return on Equity Return on Assets Addus HomeCare6.50% 9.62% 7.37% Hims & Hers Health 8.19%10.97%8.29% Do analysts prefer ADUS or HIMS? Addus HomeCare currently has a consensus price target of $133.67, indicating a potential downside of 0.15%. Hims & Hers Health has a consensus price target of $25.13, indicating a potential downside of 9.60%. Given Addus HomeCare's stronger consensus rating and higher probable upside, equities research analysts clearly believe Addus HomeCare is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.35 Which has preferable earnings and valuation, ADUS or HIMS? Addus HomeCare has higher revenue and earnings than Hims & Hers Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAddus HomeCare$1.06B2.29$62.52M$4.3730.63Hims & Hers Health$872M6.97-$23.55M$0.4463.19 Does the MarketBeat Community favor ADUS or HIMS? Addus HomeCare received 283 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.64% of users gave Addus HomeCare an outperform vote while only 39.05% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformAddus HomeCareOutperform Votes32468.64% Underperform Votes14831.36% Hims & Hers HealthOutperform Votes4139.05% Underperform Votes6460.95% Do insiders & institutionals have more ownership in ADUS or HIMS? 95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor ADUS or HIMS? In the previous week, Hims & Hers Health had 16 more articles in the media than Addus HomeCare. MarketBeat recorded 21 mentions for Hims & Hers Health and 5 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.77 beat Hims & Hers Health's score of 0.44 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAddus HomeCare beats Hims & Hers Health on 10 of the 18 factors compared between the two stocks. Get Addus HomeCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADUS vs. The Competition Export to ExcelMetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.43B$3.09B$5.36B$9.09BDividend YieldN/A0.38%5.13%4.03%P/E Ratio30.6329.9189.4717.33Price / Sales2.291.251,255.73134.95Price / Cash24.8416.0543.7535.97Price / Book3.073.415.324.80Net Income$62.52M-$57.02M$122.60M$224.91M7 Day Performance6.81%6.82%0.69%1.77%1 Month Performance2.40%4.91%1.55%2.22%1 Year Performance49.24%24.29%27.25%20.67% Addus HomeCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADUSAddus HomeCare4.6872 of 5 stars$133.87+0.4%$133.67-0.2%+49.0%$2.43B$1.06B30.6334,846Analyst DowngradeNews CoveragePositive NewsHIMSHims & Hers Health3.362 of 5 stars$25.65+0.9%$25.13-2.0%+229.9%$5.60B$1.24B58.301,046Insider TradeShort Interest ↑RDNTRadNet4.2964 of 5 stars$66.49-3.3%$84.75+27.5%+66.2%$4.92B$1.77B-949.728,970Analyst ForecastNews CoverageGHGuardant Health3.972 of 5 stars$38.28+4.3%$40.60+6.1%+58.4%$4.73B$692.26M-9.031,779Short Interest ↓OPCHOption Care Health4.7541 of 5 stars$27.72+15.5%$29.71+7.2%-9.2%$4.72B$4.78B23.295,600Analyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive NewsHigh Trading VolumeSHCSotera Health3.4335 of 5 stars$13.00-0.8%$16.08+23.7%-16.6%$3.68B$1.12B52.003,000VCYTVeracyte4.0709 of 5 stars$42.66+2.7%$41.13-3.6%+54.4%$3.31B$425.33M-284.40790Positive NewsBTSGBrightSpring Health Services2.1287 of 5 stars$17.09-0.5%$18.65+9.2%N/A$2.98B$10.59B-65.7335,000Positive NewsLFSTLifeStance Health Group1.1584 of 5 stars$7.62-1.4%$8.70+14.2%+16.5%$2.92B$1.21B-29.319,325Short Interest ↓Positive NewsSGRYSurgery Partners2.254 of 5 stars$21.01+1.7%$36.56+74.0%-36.9%$2.67B$2.99B-43.7712,200CONConcentra Group Holdings ParentN/A$20.54+4.1%$28.50+38.8%N/A$2.62B$1.88B0.0011,000Lockup ExpirationNews CoveragePositive NewsGap Down Related Companies and Tools Related Companies Hims & Hers Health Alternatives RadNet Alternatives Guardant Health Alternatives Option Care Health Alternatives Sotera Health Alternatives Veracyte Alternatives BrightSpring Health Services Alternatives LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADUS) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
